CN108157780A - 一种辅助控制体重的食品及其制备方法 - Google Patents
一种辅助控制体重的食品及其制备方法 Download PDFInfo
- Publication number
- CN108157780A CN108157780A CN201810131332.1A CN201810131332A CN108157780A CN 108157780 A CN108157780 A CN 108157780A CN 201810131332 A CN201810131332 A CN 201810131332A CN 108157780 A CN108157780 A CN 108157780A
- Authority
- CN
- China
- Prior art keywords
- parts
- food
- weight
- control body
- body weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 43
- 230000037396 body weight Effects 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims abstract description 34
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 33
- 150000004676 glycans Chemical class 0.000 claims abstract description 20
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 20
- 239000005017 polysaccharide Substances 0.000 claims abstract description 20
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940038580 oat bran Drugs 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 16
- 230000036541 health Effects 0.000 claims abstract description 13
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims description 15
- 235000013325 dietary fiber Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 5
- 229920002498 Beta-glucan Polymers 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 235000004213 low-fat Nutrition 0.000 claims description 3
- 241000207199 Citrus Species 0.000 claims description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 2
- 244000235659 Rubus idaeus Species 0.000 claims description 2
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 241000411851 herbal medicine Species 0.000 claims description 2
- 239000010903 husk Substances 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 1
- 244000099147 Ananas comosus Species 0.000 claims 1
- 235000007119 Ananas comosus Nutrition 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 235000014103 egg white Nutrition 0.000 claims 1
- 210000000969 egg white Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 6
- 239000008103 glucose Substances 0.000 abstract description 6
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 230000002641 glycemic effect Effects 0.000 abstract description 5
- 230000035755 proliferation Effects 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 230000003914 insulin secretion Effects 0.000 abstract description 2
- 230000004130 lipolysis Effects 0.000 abstract description 2
- 230000004936 stimulating effect Effects 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 150000001480 arabinoses Chemical class 0.000 abstract 1
- 235000012054 meals Nutrition 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 239000003925 fat Substances 0.000 description 8
- 244000241838 Lycium barbarum Species 0.000 description 7
- 208000008589 Obesity Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 235000020824 obesity Nutrition 0.000 description 7
- 235000015459 Lycium barbarum Nutrition 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 208000020442 loss of weight Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000186000 Bifidobacterium Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 244000241872 Lycium chinense Species 0.000 description 4
- 235000015468 Lycium chinense Nutrition 0.000 description 4
- 244000197580 Poria cocos Species 0.000 description 4
- 235000008599 Poria cocos Nutrition 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000021050 feed intake Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000016261 weight loss Diseases 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- -1 fluorine amine Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000001087 myotubule Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000013585 weight reducing agent Substances 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 101710180316 Protease 2 Proteins 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000579 abdominal fat Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001320 aldopentoses Chemical class 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000000883 anti-obesity agent Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940125710 antiobesity agent Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000019007 dietary guidelines Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000784 hepatotoxin Toxicity 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种辅助控制体重的食品及其制备方法，所述食品以100份重量计，由如下组分制成：燕麦麸30～70份、果蔬酵素粉10～30份、木糖5～30份、枸杞多糖3～15份、茯苓多糖3～15份、L‑***糖3～15份、低聚果糖1～10份。本发明具有低热量、富营养和低升糖指数，可延长能量供应时间、延续葡萄糖吸收、减少胰岛素分泌、抑制脂肪合成、加速脂肪分解、刺激人体胃肠道有益菌群的增殖和平衡，达到减肥不伤身的效果。
Description
技术领域
本发明涉及一种食品或保健食品领域，尤其涉及一种辅助控制体重的食品及其制备方法。
背景技术
肥胖是一组常见的代谢症群。当人体进食热量多于消耗热量时，多余热量以脂肪形式储存于体内，其量超过正常生理需要量，且达一定值时遂演变为肥胖症。
根据国家***的数据显示，从1992年到2015年中国人的超重率从13％上升到30％，肥胖率从3％上升到12％，同时儿童和青少年的肥胖率不断攀升；2016年英国著名医学杂志披露中国肥胖人口已经超越美国，成为全球肥胖人口最多的国家；2017年中国健康调查数据显示，中国人的肥胖指数再度飙升17％。
肥胖不仅仅只影响到人的外形，其更大的危害来自于肥胖能引起糖尿病、血脂异常、冠心病、高血压、脑卒中、癌症等疾病，对人类的健康有不可估量的伤害。
目前减肥的办法有很多种，如节食减肥、水果或酵素减肥法、药物减肥、运动减肥等，这些方法，更多关注的是热量摄入的控制，忽视了人体营养素的平衡，在减肥过程中，容易造成细胞营养不良，皮肤松弛、易肿胀，脱发；纯药物减肥潜在毒副作用，大量流失体内水分，伤害脏腑功能。一旦停止，体重迅速反弹。
发明内容
为解决上述问题，本发明的目的是提供一种辅助控制体重的食品及其制备方法，所述的食品具有低热量、富营养和低升糖指数，能延长能量供应时间、延续葡萄糖吸收、减少胰岛素分泌、抑制脂肪合成、加速脂肪分解、刺激人体胃肠道有益菌群的增殖和平衡，达到减肥不伤身的目的。本着低升糖、能量负平衡、均衡营养、胃肠道健康的四大科学理念，精选含有多种氨基酸、维生素、微量元素、蛋白质、膳食纤维的食材，合理搭配，营养满足人体所需、饱腹时间长、安全、能促进胃肠道健康、对身体部分受损细胞有针对性的进行修复，促进细胞自愈，达到安全控重、不伤身、且增强体质的作用。
本发明含有如下组分：
燕麦麸：由燕麦麸皮粉碎加工获得，目前，国际上有大量文献报道了燕麦β-葡聚糖调节血糖、血脂、软化血管、预防高血压、增强机体免疫力、预防心脑血管病、抗皮肤过敏、控制体重等功能。
β-葡聚糖是大麦燕麦水溶性膳食纤维的主要成分，是其它谷类中不具备的，具有高吸水性和持水性，具有调节人体血脂、血糖、防便秘、增强免疫力等多项保健功能。近年来国际营养学家一致认为膳食纤维能够平衡人体营养，调节机体功能。水溶性膳食纤维目前已通过美国FDA、欧洲共同体国家、日本厚生省、中国***的鉴定，被医学界、营养学界专家称为“第七营养素”，可与传统的六大营养素(即蛋白质、脂肪、水、矿物质、维生素、碳水化合物)并列。燕麦麸皮中还含有丰富的钙、磷、铁、锌、锰、铬等矿物质和微量元素，丰富的维生素B1、B2维生素E及叶酸等，可改善血液循环等多种生理功能。含有多种酶类物质，能帮助延缓细胞的衰老。
根据《中国居民膳食指南2016》版数据显示，纯燕麦麸的血糖生成指数为55，属于低GI食物。
比燕麦所含热量少很多，但单位重量各类营养成份的含量比燕麦多出数倍。
果蔬酵素粉：选用低热量、低脂肪和高纤维素的蔬菜、水果为原料，经混合发酵后制得，能加快胃部的消化和排除，帮助活跃肠道功能，加快***体内有害毒素，去积食，防便秘；营养均衡、低升糖、并能刺激体内生热***，有效地燃烧体内的脂肪，加快新陈代谢，使体内的热量消耗速度加快。
木糖：不被消化吸收，没有能量值能最大限度地满足爱吃甜品又担心发胖者的需求；活化人体肠道内的双岐杆菌并促其生长，双歧杆菌是有益菌，该菌越多越有益人体健康；食用木糖能改善人体的微生物环境，提高机体的免疫能力。不被口腔内微生物所利用，具备膳食纤维的部分生理功能，可降低血清胆固醇的预防肠癌等。木糖与食物的配伍性很好，食物中添加少量木糖，便能体现出很好的保健效果，还能防止便秘。
L-***糖：一种戊醛糖。被美国食品药品监督局和日本厚生省批准列入健康食品，可选择性地影响小肠二糖水解酶中消化蔗糖的蔗糖酶，从而抑制蔗糖的吸收。据报道,在食品中添加3.5％L-***糖，可以抑制60％～％70％蔗糖的吸收，同时也抑制了血糖值少升高约50％。美国医疗协会将其列入用做抗肥胖剂的营养补充剂或非处方药,在日本厚生省的特定保健用食品清单中，L-***糖被列入用于调节血糖的专用特殊保健食品添加剂；据三和淀粉株式会社试验证明，摄入添加5％***糖的蔗糖还可以有效促进双歧杆菌(Bifidobacterium)的生长。L-***糖本身是难以被消化道吸收的糖，在体内得不到利用的部分可从尿中排出；2005年日本的一项研究证明了L-***糖对能量消耗和肌纤维成分的影响，结果提示L-***糖有改变骨骼肌纤维成分的功效，通过支配糖酵解到糖氧化来影响腹部脂肪组织的增长。这种肌纤维比例的改变可能有改善2型糖尿病的作用
枸杞多糖：枸杞为人们对商品枸杞子、植物宁夏枸杞、中华枸杞等枸杞属下物种的统称。人们日常食用和药用的枸杞子多为宁夏枸杞的果实“枸杞子”，而且宁夏枸杞是唯一载入《2010年版中国药典》的品种，枸杞果肉的最有效成份之一，是枸杞的精华所在，易吸收，枸杞多糖是一种水溶性多糖，是枸杞中最主要的活性成分，相对分子质量为68～200，成为国内外研究热点。其中又以枸杞多糖的免疫调节和抗肿瘤作用的研究最多。现已有很多研究表明枸杞多糖具有促进免疫、抗衰老、抗肿瘤、清除自由基、抗疲劳、抗辐射、保肝、生殖功能保护和改善等作用。
茯苓多糖：从多孔菌科真菌茯苓菌核中提取的有效成分。具有免疫增强活性，可用于抗病毒、抗肿瘤，减轻放、化疗副作用，以及治疗慢性肝炎、延缓衰老等。经研究证实，茯苓多糖具有：免疫调节能力，能激活淋巴T细胞和B细胞，抗胸腺萎缩，抗脾脏增大，增强巨噬细胞吞噬能力等作用；辅助抑制肿瘤。对小鼠肉瘤S180有良好的抑制作用，有效率19.6％～35％(单用)，如与其他抑制药物(如环氟胺)共用，有效率达38.9％～69％。对白血病(L1210)能延长存活时间，单用延长70％，与环氟胺合用延长寿命168.1％；延缓衰老作用，有抑制自由基过氧化反应，降低脂质过氧化作用，减少脂褐质形成。对小鼠血清、心肌的脂褐质均有较对照组明显降低的作用；茯苓的煎液有镇静、利尿、强壮等作用，曾对贲门浮肿病人每天给予30～100g，有强的利尿作用。对兔子低血糖有改善作用。对四氯化碳引起的肝损伤有明显保护作用，防止肝细胞坏死；中医认为利水渗湿，健脾宁心。用于水肿尿少，痰多眩悸，脾虚少食，便溏泄泻，心神不安，惊悸失眠。
低聚果糖除具有一般功能性低聚糖的物理化学性质外，最引人注目的生理特性是它能明显改善肠道内微生物种群比例，它是肠内双歧杆菌的活化增殖因子，可减少和抑制肠内腐败物质的产生，抑制有害细菌的生长，调节肠道内平衡；能促进微量元素铁、钙的吸收与利用，以防止骨质疏松症；可减少肝脏毒素，能在肠中生成抗癌的有机酸，有显著的防癌功能；且口味纯正香甜可口，具有类似脂肪的香味和爽口的滑腻感。近几年低聚果糖的产品风靡日、欧、美等保健品市场。
本发明的目的是通过以下技术方案实现的：
本发明一种可辅助控制体重的食品，以100份重量计，由如下组分制成：燕麦麸30～70份、果蔬酵素粉10～30份、木糖5～30份、枸杞多糖3～15份、茯苓多糖3～15份、L-***糖3～15份、低聚果糖1～10份。
优选地，本发明一种可辅助控制体重的食品，以100份重量计，由如下组分制成：燕麦麸54份、果蔬酵素粉19份、木糖12份、枸杞多糖4份、茯苓多糖4份、L-***糖4份、低聚果糖3份。
本发明一种可辅助控制体重的食品，膳食纤维含量为25％～45％；β葡聚糖含量为≥10％。
本发明一种辅助控制体重的食品的制备方法，包括如下步骤：
(1)精选含β葡聚糖≥20％的优质燕麦麸；
(2)选用低热量、低脂肪和高纤维素的蔬菜、水果、药食两用中药材为原料，经混合发酵后制得果蔬酵素粉；所述原料按重量计，其组分含量为：柑橘15～25％、大豆10～20％、玉米10～20％、覆盆子10～20％、山药10～20％、圆苞车前子壳10～20％、食用酵母5％、菠萝蛋白酶2％。
(3)将燕麦麸54份、果蔬酵素粉19份、木糖12份、枸杞多糖4份、茯苓多糖4份、L-***糖4份、低聚果糖3份重量份在常温条件下配制成粉状混合物；
(4)将粉状混合物经干燥、灭菌后制成所述的可辅助控制体重的食品。
本发明还提供一种辅助控制体重的食品在保健品领域中的应用。
具体实施方式
下面结合实施例对本发明作进一步说明，但本发明的保护范围并不限于此。
实施例1
干燥燕麦麸、果蔬酵素粉、木糖、枸杞多糖、茯苓多糖、L-***糖、低聚果糖至含水量≦5％，按每份燕麦麸5g、果蔬酵素粉2.5g、木糖1.5g、L-***糖1g、枸杞多糖0.5g、茯苓多糖1g、低聚果糖0.5g投料，经充分搅拌均匀，经干燥、灭菌后制成含水量≦5％的颗粒状食品。每份重量为12g。
实施例2
干燥燕麦麸、果蔬酵素粉、木糖、枸杞多糖、茯苓多糖、L-***糖、低聚果糖至含水量≦5％，按每份燕麦麸7g、果蔬酵素粉2.75g、木糖1.5g、L-***糖0.5g、枸杞多糖0.5g、茯苓多糖0.5g、低聚果糖0.25g投料，经充分搅拌均匀，经干燥、灭菌后制成含水量≦5％的颗粒状食品,每份重量为13g。
实施例3
干燥燕麦麸、果蔬酵素粉、木糖、枸杞多糖、茯苓多糖、L-***糖、低聚果糖至含水量≦5％，按每份燕麦麸6g、果蔬酵素粉4g、木糖1g、L-***糖1g、枸杞多糖0.5g、茯苓多糖0.5g、低聚果糖1g投料，经充分搅拌均匀，经干燥、灭菌后制成含水量≦5％的颗粒状食品。每份重量为14g。
应用实施例1
为本发明的代餐疗法实施方案一(完全代餐方案)
用本发明的食品替代每日的正常饮食，不可吃其它的任何食品，包括饮料(不限水)。特别适用于减肥者、调理心血管或消化***及其它较严重慢性疾病，一天吃本发明的食品3餐，饥饿感严重时，可加食1～2次本食品，但全天不得超出5次。
使用方法：本发明食品用饮用水冲泡，在三餐时点食用，采用本完全代餐方案，随机抽取10例患有肥胖患者，进行食疗，使用10天后，10例患者体重均明显减轻，平均减少10kg左右。最少减重5kg，最多者达到20kg，减重的多少与患者的肥胖程度呈相关性。
应用实施例2
为本发明的代餐疗法实施方案二(不完全代餐方案)
用本发明食品在每日三餐前食用，其中二餐仅食用本发明食品，三餐外不得食用除饮用水外的其他任何食物，连续食用20天，在18例患者，所有人的体重均有明显的不同程度的降低，平均减重8kg,范围从5kg～15kg不等。减重的多少与患者的肥胖程度呈相关性。
应用实施例3
为本发明的代餐疗法实施方案三(不控食方案)
用本发明食品在每日餐前食用，进食量不做控制，患者以往的生活作息、饮食***均减重5kg,范围从2kg～10kg不等。减重的多少与患者的肥胖程度呈相关性。
以上代餐疗法，参试者均未出现不良反应，大多数参试者表示，食用期间精神状态良好，肠胃感觉较未食用前更好，大便较食用前软，而且易排出。
以上所描述的实施例是本发明一部分实施例，而不是全部的实施例。本发明的实施例的详细描述并非旨在限制要求保护的本发明的范围，而是仅仅表示本发明的选定实施例。基于本发明中的实施例，技术人员在没有作出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
Claims (5)
1.一种辅助控制体重的食品，其特征在于：以100份重量计，由如下组分制成：
燕麦麸30～70份、果蔬酵素粉10～30份、木糖5～30份、枸杞多糖3～15份、茯苓多糖3～15份、L-***糖3～15份、低聚果糖1～10份。
2.根据权利要求1所述的辅助控制体重的食品，其特征在于：以100份重量计，由如下组分制成：燕麦麸54份、果蔬酵素粉19份、木糖12份、枸杞多糖4份、茯苓多糖4份、L-***糖4份、低聚果糖3份。
3.根据权利要求1或2所述的辅助控制体重的食品，其特征在于：它含有下述重量百分含量的有效成份：
膳食纤维含量为25～45％；
β葡聚糖含量为≥10％。
4.根据权利要求1所述的辅助控制体重的食品的制备方法，其特征在于：它包括如下步骤：
(1)精选含β葡聚糖≥20％的优质燕麦麸；
(2)选用低热量、低脂肪和高纤维素的蔬菜、水果、药食两用中药材为原料，经混合发酵后制得果蔬酵素粉；所述原料按重量计，其组分含量为：柑橘15～25％、大豆10～20％、玉米10～20％、覆盆子10～20％、山药10～20％、圆苞车前子壳10～20％、食用酵母5％、菠萝蛋白酶2％；
(3)将燕麦麸、果蔬酵素粉、木糖、枸杞多糖、茯苓多糖、L-***糖、低聚果糖按重量份在常温条件下配制成粉状混合物；
(4)将粉状混合物经干燥、灭菌后制成所述的辅助控制体重的食品。
5.权利要求1或2所述的辅助控制体重的食品在保健品领域中的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810131332.1A CN108157780A (zh) | 2018-02-09 | 2018-02-09 | 一种辅助控制体重的食品及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810131332.1A CN108157780A (zh) | 2018-02-09 | 2018-02-09 | 一种辅助控制体重的食品及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108157780A true CN108157780A (zh) | 2018-06-15 |
Family
ID=62513875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810131332.1A Pending CN108157780A (zh) | 2018-02-09 | 2018-02-09 | 一种辅助控制体重的食品及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108157780A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102511713A (zh) * | 2011-12-20 | 2012-06-27 | 内蒙古伊利实业集团股份有限公司 | 复合膳食纤维溶液、其制备及其蛋白饮料 |
| CN106235321A (zh) * | 2016-09-30 | 2016-12-21 | 广州诗而蓝贸易有限公司 | 一种复合植物酵素及其应用 |
| CN106579389A (zh) * | 2016-12-17 | 2017-04-26 | 河北御芝林生物科技有限公司 | 一种通便、减肥、美容、增强免疫力的组合物 |
| CN106579387A (zh) * | 2016-12-16 | 2017-04-26 | 南京糖防生物科技有限公司 | 一种***糖酵素组合物及制备方法 |
| CN106722931A (zh) * | 2016-11-10 | 2017-05-31 | 甘洛县彝家山寨农牧科技有限公司 | 一种调理肠胃和改善便秘的组合物及其制备方法 |
| CN106954856A (zh) * | 2017-04-27 | 2017-07-18 | 河南佳禾康生物食品科技有限公司 | 一种酵素膳食纤维及其制备工艺 |
-
2018
- 2018-02-09 CN CN201810131332.1A patent/CN108157780A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102511713A (zh) * | 2011-12-20 | 2012-06-27 | 内蒙古伊利实业集团股份有限公司 | 复合膳食纤维溶液、其制备及其蛋白饮料 |
| CN106235321A (zh) * | 2016-09-30 | 2016-12-21 | 广州诗而蓝贸易有限公司 | 一种复合植物酵素及其应用 |
| CN106722931A (zh) * | 2016-11-10 | 2017-05-31 | 甘洛县彝家山寨农牧科技有限公司 | 一种调理肠胃和改善便秘的组合物及其制备方法 |
| CN106579387A (zh) * | 2016-12-16 | 2017-04-26 | 南京糖防生物科技有限公司 | 一种***糖酵素组合物及制备方法 |
| CN106579389A (zh) * | 2016-12-17 | 2017-04-26 | 河北御芝林生物科技有限公司 | 一种通便、减肥、美容、增强免疫力的组合物 |
| CN106954856A (zh) * | 2017-04-27 | 2017-07-18 | 河南佳禾康生物食品科技有限公司 | 一种酵素膳食纤维及其制备工艺 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101347193B (zh) | 能够提供均衡营养的复合米及其制作工艺 | |
| CN106954847A (zh) | 具有润肠通便功能的酵素益生菌组合物、应用及加工制剂 | |
| CN108272073A (zh) | 一种减肥代餐粉及其制备方法 | |
| CN104643250B (zh) | 一种可双向调节体重改善亚健康的固体饮料 | |
| CN102813120B (zh) | 海参防癌降糖面粉及制备方法 | |
| CN106261763A (zh) | 一种谷物膳食纤维代餐粉及其制备方法 | |
| CN104431741A (zh) | 一种谷物调理粥及其制备方法和用途 | |
| CN108294318A (zh) | 一种减肥及控制体重的功能食品 | |
| CN104605353A (zh) | 适用于手术后肿瘤患者食用的配方食品及其制备方法 | |
| KR101611954B1 (ko) | 변비 및 피로회복 개선 기능을 가지는 발효광물 생식 환의 제조방법 및 이에 따라 제조된 발효광물 생식 환 | |
| CN104855983A (zh) | 冠心病非全营养配方食品 | |
| CN109329930A (zh) | 一种促进尿酸降低的组合物及其制备方法 | |
| CN104839695A (zh) | 炎性肠病非全营养配方食品 | |
| KR20150094507A (ko) | 고구마칩, 브로콜리 과립과 식이섬유를 포함하는 변비개선용 시리얼 및 그의 제조방법 | |
| CN105707681A (zh) | 一种具有降血糖功能的超微黑木耳粉营养粥及其制备方法 | |
| CN105707378A (zh) | 黑青稞瘦身咖啡 | |
| CN104161266A (zh) | 脾胃虚寒全营养配方食品 | |
| CN1224339C (zh) | 一种降糖通便的营养保健食品 | |
| CN109043259A (zh) | 一种酵素l-***糖水苏糖复合饮料浓浆 | |
| CN101524153A (zh) | 益于糖尿病人的保健小麦面粉 | |
| CN109043555A (zh) | 一种高血糖患者食用的特殊食品及其制备方法 | |
| CN115590069A (zh) | 一种含有豌豆肽的组合物及其制备方法和应用 | |
| CN101897439B (zh) | 一种保健食品 | |
| CN108157780A (zh) | 一种辅助控制体重的食品及其制备方法 | |
| CN104336511A (zh) | 一种营养均衡的粗粮颗粒及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180615 |
|
| WD01 | Invention patent application deemed withdrawn after publication |